García-Covarrubias Aldo, Morales Jorge, Espinosa Valeria, Rodríguez María Del Pilar, Torres Andrea, Zalazar Alejandro, Hernández Angélica, Alcántara Dulce, Hernández-River Juan C, Hernández Angélica, Ortuño Danahé, García-Covarrubias Luis
Department of Organ Donation, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, México.
Transplant Department, Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, México.
Transplant Proc. 2020 May;52(4):1136-1139. doi: 10.1016/j.transproceed.2020.02.008. Epub 2020 Apr 16.
The Kidney Donor Profile Index (KDPI) was created in 2014 to measure the likelihood of graft failure for a given donor compared with the median kidney donor from the previous year. This scale is based on the American population only. Mexico is one of the countries with greater incidence of chronic kidney disease, a long waiting list, and not enough kidney donors with KDPI smaller than 80%. This has led transplant centers to take kidney grafts with a higher KDPI.
To investigate the agreement between the KDPI and histologic scores (preimplantation renal biopsy) and assess the relationship between the Kidney Donor Risk Index (KDRI), KDPI, and the histologic score on graft survival.
A retrospective, analytical, transversal study was performed. Data were collected from patients with kidney grafts from deceased donors from January 1, 2011, to June 30, 2019, at our hospital. The variables analyzed were age, weight, height, sex, race and/or ethnicity, history of hypertension or diabetes, cause of death, serum creatinine, KDPI, KDRI, and biopsy result from each graft prior to transplant.
The total population was 59 deceased kidney donors. For our patients, a high KDPI did not increase mortality rate; it provided greater benefit than staying on dialysis.
We conclude that the use of KDRI should only be considered to assess the degree of fibrosis, not to rule out a transplantable kidney, in addition to the consistent demonstration that high KDPI kidneys (even 91%-100%) confer greater survival benefits to patients regarding the waiting list.
肾脏供体特征指数(KDPI)于2014年创建,用于衡量给定供体与上一年度肾脏供体中位数相比移植失败的可能性。该量表仅基于美国人群。墨西哥是慢性肾病发病率较高、等待名单较长且KDPI低于80%的肾脏供体不足的国家之一。这导致移植中心采用KDPI较高的肾脏进行移植。
研究KDPI与组织学评分(植入前肾活检)之间的一致性,并评估肾脏供体风险指数(KDRI)、KDPI与移植存活组织学评分之间的关系。
进行了一项回顾性、分析性横断面研究。收集了2011年1月1日至2019年6月30日在我院接受已故供体肾脏移植患者的数据。分析的变量包括年龄、体重、身高、性别、种族和/或民族、高血压或糖尿病病史、死亡原因、血清肌酐、KDPI、KDRI以及移植前每个移植物的活检结果。
总共有59名已故肾脏供体。对于我们的患者,高KDPI并未增加死亡率;与继续接受透析相比,它带来了更大的益处。
我们得出结论,除了一致表明高KDPI的肾脏(即使是91%-100%)在等待名单方面为患者带来更大的生存益处外,KDRI的使用仅应考虑用于评估纤维化程度,而不是排除可移植的肾脏。